Cheezheng Tibetan Medicine Co. has been approved to IPO on the Shenzhen exchange. It will offer up to 41 million shares in the offering. The approval gives evidence that the IPO market in China is continuing to open for life science companies, following the almost year-long absence of any activity as worldwide financial markets imploded. Established in 1992, Cheezheng Tibetan was the first pharmaceutical company in Tibet to be granted GMP certification. The company offers products that are drawn from the practices of traditional Tibetan Medicine. More details...